Heron Therapeutics vs Natural Alternatives International
Heron Therapeutics and Natural Alternatives International are similar in size: $155m and $143m of revenue in their latest fiscal years. Natural Alternatives International grew faster (9.7% against 7.4%). Heron Therapeutics kept more of each dollar of sales as profit: a net margin of -13.0% against -14.5%.
| Latest fiscal year | Heron TherapeuticsHRTX, 2025 | Natural Alternatives InternationalNAII, 2026 |
|---|---|---|
| Revenue | $155m | $143m |
| Revenue growth | 7.4% | 9.7% |
| Net income | −$20.2m | −$20.7m |
| Operating margin | -1.6% | — |
| Net margin | -13.0% | -14.5% |
| Return on equity | — | -35.0% |
| Free cash flow | −$27.9m | −$12.6m |
| Cash | $28.6m | $7.4m |
| Total debt | $32.7m | $18.0m |
| Debt to equity | 228.4% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | $89,000 |
| Employees | 128 | 219 |
| Market value | $52.7m | $6.7m |
| Price vs our value range | — | — |
| Moat score | 17 (Weak) | 27 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 14 buys, 0 sales |